JPS62186787A - Novel microorganism - Google Patents
Novel microorganismInfo
- Publication number
- JPS62186787A JPS62186787A JP3010086A JP3010086A JPS62186787A JP S62186787 A JPS62186787 A JP S62186787A JP 3010086 A JP3010086 A JP 3010086A JP 3010086 A JP3010086 A JP 3010086A JP S62186787 A JPS62186787 A JP S62186787A
- Authority
- JP
- Japan
- Prior art keywords
- positive
- ss50732a
- agar
- medium
- negative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 244000005700 microbiome Species 0.000 title abstract description 13
- 230000003115 biocidal effect Effects 0.000 claims abstract description 5
- 241000894006 Bacteria Species 0.000 claims description 16
- 239000000203 mixture Substances 0.000 abstract description 27
- 239000002609 medium Substances 0.000 abstract description 26
- 239000000126 substance Substances 0.000 abstract description 21
- 210000004027 cell Anatomy 0.000 abstract description 10
- 230000012010 growth Effects 0.000 abstract description 8
- 229920002472 Starch Polymers 0.000 abstract description 7
- 238000012258 culturing Methods 0.000 abstract description 7
- 239000008107 starch Substances 0.000 abstract description 7
- 235000019698 starch Nutrition 0.000 abstract description 7
- 239000002689 soil Substances 0.000 abstract description 5
- 210000002421 cell wall Anatomy 0.000 abstract description 4
- 239000007788 liquid Substances 0.000 abstract description 4
- 229910002651 NO3 Inorganic materials 0.000 abstract description 3
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 abstract description 3
- LFYJSSARVMHQJB-QIXNEVBVSA-N bakuchiol Chemical compound CC(C)=CCC[C@@](C)(C=C)\C=C\C1=CC=C(O)C=C1 LFYJSSARVMHQJB-QIXNEVBVSA-N 0.000 abstract description 3
- 230000000813 microbial effect Effects 0.000 abstract description 3
- 108010010803 Gelatin Proteins 0.000 abstract description 2
- 239000001913 cellulose Substances 0.000 abstract description 2
- 229920002678 cellulose Polymers 0.000 abstract description 2
- 238000005345 coagulation Methods 0.000 abstract description 2
- 230000015271 coagulation Effects 0.000 abstract description 2
- 238000000354 decomposition reaction Methods 0.000 abstract description 2
- 239000008273 gelatin Substances 0.000 abstract description 2
- 229920000159 gelatin Polymers 0.000 abstract description 2
- 235000019322 gelatine Nutrition 0.000 abstract description 2
- 235000011852 gelatine desserts Nutrition 0.000 abstract description 2
- 230000007062 hydrolysis Effects 0.000 abstract description 2
- 238000006460 hydrolysis reaction Methods 0.000 abstract description 2
- 239000000049 pigment Substances 0.000 abstract description 2
- 239000007172 yeast starch agar Substances 0.000 abstract description 2
- 239000007175 yeast-starch-agar Substances 0.000 abstract description 2
- 235000020247 cow milk Nutrition 0.000 abstract 2
- 241000187362 Actinomadura Species 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 39
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 29
- 229920001817 Agar Polymers 0.000 description 28
- 239000008272 agar Substances 0.000 description 28
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- 239000000243 solution Substances 0.000 description 15
- 238000000034 method Methods 0.000 description 14
- 239000003242 anti bacterial agent Substances 0.000 description 11
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 10
- 229940088710 antibiotic agent Drugs 0.000 description 9
- 238000004440 column chromatography Methods 0.000 description 9
- 230000001580 bacterial effect Effects 0.000 description 8
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 238000000862 absorption spectrum Methods 0.000 description 6
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 230000001766 physiological effect Effects 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 239000000741 silica gel Substances 0.000 description 5
- 229910002027 silica gel Inorganic materials 0.000 description 5
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 229960001230 asparagine Drugs 0.000 description 4
- 235000009582 asparagine Nutrition 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000004809 thin layer chromatography Methods 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 229920005654 Sephadex Polymers 0.000 description 3
- 239000012507 Sephadex™ Substances 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 239000003708 ampul Substances 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 230000008014 freezing Effects 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 241001446247 uncultured actinomycete Species 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- SRBFZHDQGSBBOR-SOOFDHNKSA-N D-ribopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@@H]1O SRBFZHDQGSBBOR-SOOFDHNKSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000187747 Streptomyces Species 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 235000011941 Tilia x europaea Nutrition 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 2
- 239000007640 basal medium Substances 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 235000012343 cottonseed oil Nutrition 0.000 description 2
- 239000000287 crude extract Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000012136 culture method Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 229930182830 galactose Natural products 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000004571 lime Substances 0.000 description 2
- -1 madulose Chemical compound 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 2
- 235000013923 monosodium glutamate Nutrition 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000006916 nutrient agar Substances 0.000 description 2
- 239000006877 oatmeal agar Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 230000009897 systematic effect Effects 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- GMKMEZVLHJARHF-UHFFFAOYSA-N (2R,6R)-form-2.6-Diaminoheptanedioic acid Natural products OC(=O)C(N)CCCC(N)C(O)=O GMKMEZVLHJARHF-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- 241000157200 Actinomadura yumaensis Species 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 241000203578 Microbispora Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 241000187264 Planomonospora Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 240000005608 Ranunculus bulbosus Species 0.000 description 1
- 235000000903 Ranunculus bulbosus Nutrition 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 241000576755 Sclerotia Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- PNNNRSAQSRJVSB-BXKVDMCESA-N aldehydo-L-rhamnose Chemical compound C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O PNNNRSAQSRJVSB-BXKVDMCESA-N 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 230000009422 growth inhibiting effect Effects 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- GMKMEZVLHJARHF-SYDPRGILSA-N meso-2,6-diaminopimelic acid Chemical compound [O-]C(=O)[C@@H]([NH3+])CCC[C@@H]([NH3+])C([O-])=O GMKMEZVLHJARHF-SYDPRGILSA-N 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- XELZGAJCZANUQH-UHFFFAOYSA-N methyl 1-acetylthieno[3,2-c]pyrazole-5-carboxylate Chemical compound CC(=O)N1N=CC2=C1C=C(C(=O)OC)S2 XELZGAJCZANUQH-UHFFFAOYSA-N 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000004223 monosodium glutamate Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000002897 organic nitrogen compounds Chemical class 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 239000012925 reference material Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 210000001050 stape Anatomy 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000004565 tumor cell growth Effects 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明はアクチノマジユラ属に属する新規な微生物に関
し、更に詳細には新規な抗生物質SS50732A、B
及びCを採取することのできる新規な微生物に関する。DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to a novel microorganism belonging to the genus Actinomadilla, and more particularly to novel antibiotics SS50732A and B.
and a novel microorganism from which C can be collected.
従来、アクチノマジユラ属に属する菌株はいくつか知ら
れているが、ストレプトミセス属に属する菌株と比較し
た場合その数はきわめて少ない。Several strains belonging to the genus Actinomadilla have been known, but their number is extremely small compared to strains belonging to the genus Streptomyces.
しかもアクチノマジユラ属によって生産される抗生物質
はl”R−900405及びFR−、c+oo4o6C
ジャーナル・オブ・アンチバイオチフス(Tu JOU
llAL。Moreover, the antibiotics produced by the genus Actinomadilla are l"R-900405 and FR-, c+oo4o6C
Journal of Antibiotyphoid Fever (Tu JOU
llAL.
IJF ANTIBIOTIC8) 、 38巻、83
5〜839頁。IJF ANTIBIOTIC8), Volume 38, 83
Pages 5-839.
840〜848頁(1985年)〕や5F−2140C
ジャーナル・オプ・アンチバイオチフス(T)LF:
JOURNALOF ANTIBIOTIC8)、 3
7巻、931〜934頁、同1144〜1148頁(1
984年)〕などが知られているのみで、その数もきわ
めて限られていた。840-848 (1985)] and 5F-2140C
Journal of Antibiotics (T)LF:
JOURNAL OF ANTIBIOTIC8), 3
Volume 7, pp. 931-934, pp. 1144-1148 (1
984)], and their number was extremely limited.
本発明者らは、医薬あるいは動物薬として有用な抗生物
質及び生理活性物質を生産する新規微生物を得べく、天
然の土壌より数多くの微生物を単離し、その生産物につ
いて種々研究を行なった。The present inventors isolated a large number of microorganisms from natural soil and conducted various studies on their products in order to obtain new microorganisms that produce antibiotics and physiologically active substances useful as medicines or veterinary medicines.
そして、その結果、千葉県夷隅郡の土壌より分離採取し
たアクチノマジユラ属に属する微生物は医薬として有用
な新規抗生物質SS50732A、B及びCを生産する
ことを見出し、本発明を完成した。As a result, the present invention was completed by discovering that microorganisms belonging to the genus Actinomagilla isolated and collected from soil in Isumi District, Chiba Prefecture produce novel antibiotics SS50732A, B, and C useful as medicines.
したがって本発明はアクチノマジユラ属に属する新規抗
生物質SS50732A、 B及びC生産菌を提供する
ものである。Therefore, the present invention provides bacteria producing novel antibiotics SS50732A, B, and C belonging to the genus Actinomadilla.
本発明の微生物を土壌から分離するだめの方法の一例を
挙げれば次の通りである。すなわち、まず、採取した土
壌の懸濁液上層液を通常の組成の寒天平板に塗抹して2
7〜30℃で20〜30日間培養し、発生した微生物の
コロニーを通常の組成の球入斜面に分離して、27〜3
0℃で7〜14日間培養し、多数の菌株を得る。次いで
それらの菌株を逐一、通常の組成の培地で27〜30℃
で3〜5日間振盪培養し、それらの培養液の抗菌活性を
種々の試験菌を用いて試l倹し、この中から抗菌活性を
有する菌株を選出する。更にそれらの菌株について更に
精細に試験し、培養液中に後記のSS50732A、B
及びCと名付けた抗生物質を産生ずるものを選択分離す
る。An example of the method for separating the microorganisms of the present invention from soil is as follows. That is, first, the upper layer of the suspension of the collected soil was smeared onto an agar plate with a normal composition.
After culturing at 7 to 30°C for 20 to 30 days, the microbial colonies that emerged were separated into spheres with a normal composition, and 27 to 3
Cultivate at 0°C for 7 to 14 days to obtain a large number of strains. Then, each strain was incubated at 27-30°C in a medium with a normal composition.
The culture is cultured with shaking for 3 to 5 days, and the antibacterial activity of the culture solution is tested using various test bacteria, and strains having antibacterial activity are selected from among them. Furthermore, these strains were tested in more detail, and SS50732A and B described later were added to the culture solution.
and selectively isolate those that produce an antibiotic named C.
このようにして得られた本発明の微生物の一つである8
50732株は次のような菌学的性質を有する。8, which is one of the microorganisms of the present invention obtained in this way.
Strain 50732 has the following mycological properties.
(I)形態学的性質
栄養菌糸はグリセリン・アスパラギン寒天培地、スター
チ寒天培地、イースト・麦芽寒天培地、オートミール寒
天培地、チロシン寒天培地、栄養寒天培地、リンゴ酸・
石灰寒天培地で中程度に発達し、不規則に分枝するが通
常は隔壁を有しない。(I) Morphological properties Vegetative hyphae can be grown on glycerin/asparagine agar, starch agar, yeast/malt agar, oatmeal agar, tyrosine agar, nutrient agar, malic acid/
Moderately developed on lime agar, irregularly branched but usually without septa.
気菌糸はスターチ寒天培地、オートミール寒天培地、リ
ンゴ酸・石灰寒天培地で中程度に、グリセリ/・アスパ
ラギン寒天培地、グリセリン・硝酸塩寒天培地、チロシ
ン寒天培地、栄養寒天培地では貧弱に着生し、はとんど
が黄みの白色からうすい黄みのピンクを呈する。シュク
ロース・硝酸塩寒天培地、グルコース・アスパラギン寒
天培地、イースト・麦芽寒天培地では着生しない。顕微
鏡下での観察では胞子柄に10−前後の連鎖をもつ胞子
鎖を着生する。胞子の大きさは0.6〜0.9×1.0
〜1.3μでほぼ卵形である。胞子の表面は不定形であ
る。1核、胞子のう及び遊走子は観察されない。Aerial mycelium grows moderately on starch agar, oatmeal agar, malic acid/lime agar, and poorly on glycerin/asparagine agar, glycerin/nitrate agar, tyrosine agar, and nutrient agar; The tongs are yellowish white to pale yellowish pink. It does not grow on sucrose/nitrate agar, glucose/asparagine agar, or yeast/malt agar. When observed under a microscope, spore chains with around 10 chains are attached to the sporophyte. Spore size is 0.6-0.9 x 1.0
~1.3μ and almost oval in shape. The surface of the spore is amorphous. Single nuclei, sporangia and zoospores are not observed.
(n)各種培地上での性状
850732株の各種培地での生育状態は次表の通シで
ある。観察は28℃、14日間培養後に行なった。なお
、色の記載は、日本色研事業■発行(昭和56年「色名
小事典」の系統色名で行なった。(n) Properties on various media The growth state of strain 850732 on various media is as shown in the following table. Observations were made after culturing at 28°C for 14 days. The colors are described using the systematic color names from the "Small Dictionary of Color Names" published by Nippon Shikiken Business ■ (1982).
また、表中括弧内は色標番号を示す。In addition, the number in parentheses in the table indicates the color standard number.
(1)生理的諸性質
+1)生育温度範囲(イースト・スターチ寒天培地、1
4日間培養)
生育至適温度 30〜40°C生育可能温
度 18〜43℃(2)ゼラチンの液化
陽性(3)スターチの加水分解
陰性(4)脱脂牛乳の凝固 陽性ペ
プトン化 陽性
(5)メラニン様色素の生成 陰性(6)硝酸
塩の還元 陽性(カセルロースの分解
陰性(IV)炭素源の同化性(28℃、
14日培養)プリドハム・ゴドリープ寒天培地を基礎培
地とした場合、グルコースを加えた培地での生育が悪く
、糖無添加培地との生育に差が認められない。(1) Physiological properties + 1) Growth temperature range (yeast starch agar medium, 1
4-day culture) Optimum growth temperature: 30-40°C Growth temperature: 18-43°C (2) Liquefaction of gelatin
Positive (3) Hydrolysis of starch
Negative (4) Coagulation of skim milk Positive peptonization Positive (5) Production of melanin-like pigments Negative (6) Reduction of nitrates Positive (decomposition of cellulose Negative (IV) Assimilation of carbon sources (28℃,
14-day culture) When Pridham-Godliep agar medium is used as the basal medium, growth is poor in the medium containing glucose, and no difference in growth is observed between the medium and the medium without sugar.
したがって、プリドハム・ゴドリープ寒天培地に14L
−アスパラギンを加えたものを基礎培地とする。Therefore, 14 L on Pridham-Godliep agar
- Use asparagine as the basal medium.
L−アラビノース、D−グルコース、D−キシロース、
D−マンニトール、D−フルクトース、L−ラムノース
を利用し、シュクロース、イノシトール、ラフィノース
、ガラクトース、マンノース、イヌリンは利用しない。L-arabinose, D-glucose, D-xylose,
D-mannitol, D-fructose, and L-rhamnose are used, but sucrose, inositol, raffinose, galactose, mannose, and inulin are not used.
(v)細胞の化学分析
(1)細胞壁組成
ジアミノピメリン酸はメン型で、グリシンを有せず、ア
ラビノースは認められない。(v) Chemical analysis of cells (1) Cell wall composition Diaminopimelic acid is of men type, has no glycine, and no arabinose is observed.
(2)全菌体の糖組成
アラビノース、キシロースヲ有さす、マジュロース、ガ
ラクトース、リボース、クルコースを有する。(2) Sugar composition of the whole bacterial cell Contains arabinose, xylose, madulose, galactose, ribose, and crucose.
したがって、リシパリエ(Inter、 J、 Sys
tem。Therefore, Licipalier (Inter, J, Sys
tem.
Bact、 20巻、435i 〜443貞、1970
)の分類にしたがったこの菌の細胞壁組成(cell
walltype )は夏型、全菌体の糖組成(Wh
ole cell augarpattern )はB
型となる。Bact, vol. 20, 435i ~ 443 Sada, 1970
The cell wall composition of this bacterium according to the classification of
walltype) is the summer type, and the sugar composition of the whole bacterial cell (Wh
ole cell agar pattern) is B
Becomes a mold.
以上、この菌は細胞壁組成と全菌体の糖組成がin型で
あることから、ミクロビスポーラ属、ストレプトスボラ
ンギウム属、スビリロスポーラ属、プラノモノスポーラ
属、デルマドフィーラス属、アクチノマジユラ属のいず
れかに属するものと考えられる。しかしながら、その形
態においても胞子柄に10個前後の連鎖をもつ胞子鎖を
着生し、菌核、胞子のう及び遊走子が見出され゛ないこ
とより、この菌はアクチノマジユラ属(Genus A
ctino−madura )に属することが明らかで
ある。ところで、現在、アクテノマジュラ属に属する種
としては30種が承認及び有効公表と認められているが
(後記文献(1)〜(3)参照)、前記の菌学的性質を
有すると思われる種は認められず、したがって本菌株を
アクチノマジユラ属に属する新菌株と判断し、アクチノ
マジユラ・エスピー850732 (Actinoma
durasp、 850732 )として工業技術院微
生物工業技術研究所に受託番号微工研菌寄第8613号
(FERMP −8613)として寄託した。As mentioned above, since this bacterium has an in-type cell wall composition and a sugar composition of the entire bacterial body, it has been shown that Microbispora, Streptosborangium, Svirirospora, Planomonospora, Dermadophilus, and Actinomagilla It is thought to belong to one of the genus. However, even in this form, spore chains with around 10 chains are attached to the sporophyte, and no sclerotia, sporangia, or zoospores have been found, indicating that this fungus belongs to the genus Actinomagilla. A
ctino-madura). By the way, currently, 30 species belonging to the genus Actenomadula have been approved and officially published (see references (1) to (3) below), but the species that are thought to have the above-mentioned mycological properties are Therefore, this bacterial strain was judged to be a new strain belonging to the genus Actinomagiula, and was classified as Actinomagiula sp. 850732 (Actinomagiula sp.
durasp, 850732) and was deposited with the National Institute of Microbiology, Agency of Industrial Science and Technology under accession number FERMP-8613.
文献: +11 Skerman、 V、B、D、、
V、 Me Gowan、 andP、比A、 5ne
ath(ed、)、 1980. Approved
1istsof bacterial names、
Int、 J、5yst、 Bacte−riol、
33 : 225−420(2)WJ、C,Moor
e、 Elizabeth P、 Cato、 and
Lillian V、H,Moore、1985.In
dex of theBacterial and
Yeast NomenclaturalChang
es Published in the Inter
natinalJournal of Systema
tic BacteriologySince the
1980 Approved Li5ts ofBa
cterial Names (l January
1980 t。Literature: +11 Skerman, V.B.D.
V, Me Gowan, andP, ratio A, 5ne
ath (ed.), 1980. Approved
1istsof bacterial names,
Int, J, 5yst, Bacte-riol,
33: 225-420 (2) W.J., C., Moor.
e, Elizabeth P., Cato, and
Lillian V, H, Moore, 1985. In
dex of the Bacterial and
Yeast NomenclaturalChang
es Published in the Inter
National Journal of Systema
tic Bacteriology Since the
1980 Approved Li5ts ofBa
cterial Names (l January
1980t.
I January 1985 )、 Int、 J、
5yst。I January 1985), Int, J.
5yst.
Bacteriol、35: 382−407(3)
D、P、Labeda、 R,T、Te5ta、 M
、P、Lechevalier。Bacteriol, 35: 382-407(3)
D, P, Labeda, R, T, Te5ta, M
, P. Lechevalier.
and H,A、Lechevalier、1985.
Actinoma−dura yumaensis a
p、 nov、 Int、 J、 5yat。and H, A, Lechevalier, 1985.
Actinoma-dura yumaensis a
p, nov, Int, J, 5yat.
Bacteriol、35: 333−336本発明
の微生物を用いる、新規抗生物質 8850732A、
B及びCの製造は、例えば次の如くして行なわれる。Bacteriol, 35: 333-336 Novel antibiotic 8850732A using the microorganism of the present invention,
B and C are produced, for example, as follows.
すなわち、本発明菌株の培養には、通常の放線菌の培養
法が用いられる。栄養培地としては、資化しうる炭素源
、窒素源、無機物などを適当に含有する限り、合成培地
、半合成培地あるいは天然培地のいずれでも使用可能で
ある。炭素源としては、例えばグルコース澱粉、フルク
トース等が単独または組合せて用いられる。更に菌の資
化性によって・:ri、、炭化水素、アルコール類、有
機酸も用い得る。窒素源としては、無機もしくは有機窒
素化合物、例えば塩化アンモニウム、硫酸アンモニウム
、硝酸アンモニウム、尿素、硝酸ナトリウム、グルタミ
ン酸ナトリウム等;または天然物、例えば大豆粉、酵母
エキス、NZアミン、ペプトン、肉エキス、乾燥酵母、
綿実粕、プロテオースベプトン、カザミノ酸、コーン・
ステイープ・リカー等が単独または組合せて用いられる
。また、無機物としては、例えば炭酸カルシウム、塩化
ナトリウム、硫酸銅、硫酸マンガン、硫酸亜鉛、硫酸鉄
等示単独または組合せて用いられる。その他85073
2株の発育を助けSS50732A%B及びCの生産を
促進する物質あるいはシリコン油またはアデカノール(
商品名)等の一般的消泡剤を適宜培地に添加することも
できる。That is, the usual method for culturing actinomycetes is used to culture the strain of the present invention. As the nutrient medium, any synthetic medium, semi-synthetic medium, or natural medium can be used as long as it contains appropriate amounts of assimilable carbon sources, nitrogen sources, inorganic substances, and the like. As the carbon source, for example, glucose starch, fructose, etc. may be used alone or in combination. Furthermore, depending on the assimilation ability of the bacteria, hydrocarbons, alcohols, and organic acids may also be used. As nitrogen sources, inorganic or organic nitrogen compounds, such as ammonium chloride, ammonium sulfate, ammonium nitrate, urea, sodium nitrate, monosodium glutamate, etc.; or natural products, such as soy flour, yeast extract, NZ amine, peptone, meat extract, dried yeast,
Cottonseed meal, proteose beptone, casamino acids, corn
Stape liquor and the like may be used alone or in combination. Examples of inorganic substances include calcium carbonate, sodium chloride, copper sulfate, manganese sulfate, zinc sulfate, iron sulfate, etc., which may be used alone or in combination. Others 85073
Substances that help the growth of the two strains and promote the production of SS50732A%B and C, or silicone oil or Adekanol (
A general antifoaming agent such as (trade name) can also be added to the medium as appropriate.
培養法としては、前記の如く一般の放Ifs菌の培養に
用いられる方法が採用されるが、液体培養法、特に深部
攪拌培養法が最も適している。培養は好気的条件で行な
われ、培養に適当な温度は20〜35℃である。As the culture method, the method generally used for culturing the Ifs bacteria as described above is employed, but the liquid culture method, particularly the deep agitation culture method, is most suitable. Cultivation is carried out under aerobic conditions, and a suitable temperature for culturing is 20-35°C.
SS50732A、B及びCは振盪培養、深部攪拌培養
法のいずれ−の場合にもその生産址は3〜5日間の培養
で最高に達する。培養中のSS50732A、B及びC
の蓄積量が最高に達した時にf@養を停止し、培養液中
から目的物質を単離して精製する。SS50732A, B, and C reach their maximum production after 3 to 5 days of culture in both shaking culture and deep agitation culture. SS50732A, B and C in culture
When the accumulated amount of f@ reaches the maximum, the f@ culture is stopped, and the target substance is isolated and purified from the culture solution.
培#液中からのSS50732A、 B及びCの単離は
、後記参考例に示す如く、当該化合物の理化学的性状を
考慮して種々の方法を単独であるいは適宜組合せること
によって行なわれる。すなわち、SS50732A、B
及びCは通常培養p液及び菌体中に存在するので、培養
液を遠心分離または濾過等によって培養P液と菌体とに
分離し、これらから通常の分離手段、例えば溶媒抽出法
、イオン交換樹脂法、ゲルー過法、吸着または分配カラ
ムクロマト法、高速液体クロマト法、透析法、沈澱法な
どを単独でまたは適宜組合せて実施することにより分離
・精製される。また、培養液を塩酸あるいは硫酸等酸性
物質により強酸性とし、しばらく放置後、遠心分離また
は濾過等によシ残渣を得て、これより上記通常の分離手
段によfiSS50732A、B及びCを分離・精製す
ることもできる。Isolation of SS50732A, B, and C from the culture medium is carried out by using various methods alone or in appropriate combinations, taking into account the physical and chemical properties of the compounds, as shown in the Reference Examples below. That is, SS50732A,B
and C are normally present in the culture P solution and the bacterial cells, so the culture solution is separated into the culture P solution and the bacterial cells by centrifugation or filtration, and these are separated using conventional separation methods such as solvent extraction and ion exchange. Separation and purification are carried out by resin method, gel filtration method, adsorption or distribution column chromatography method, high performance liquid chromatography method, dialysis method, precipitation method, etc. alone or in appropriate combinations. In addition, the culture solution is made strongly acidic with an acidic substance such as hydrochloric acid or sulfuric acid, and after being left for a while, a residue is obtained by centrifugation or filtration, and from this, fiSS50732A, B, and C are separated by the above-mentioned normal separation means. It can also be purified.
好ましい分離・精製の例としては、次の方法が挙げられ
る。Examples of preferable separation and purification include the following methods.
まず、醗酵を終了した培養/in塩酸によりp)I2と
し、しばらく放置後遠心分離することにより1体を含む
残渣を得る。これを塩rII酸性丁において、クロロホ
ルムメタノール混液(2:1.v/v)により抽出する
。抽出液の溶媒を留去し、n−ヘキサンあるいは石油エ
ーテルで洗った後、残渣をシリカゲルカラムクロマトグ
ラフィーに付す。次に適当なl@#i!液、例えばクロ
ロホルム・メタノール混液等で溶出すると、まずSS5
0732A画分が溶出され、次にSS50732Bti
ui分、更に58507320画分が溶出される。更に
各両分をセファデックスLH20(ファルマシア社製)
カラムクロマトグラフィーに付し、適当な溶離液例えば
クロロホルム・メタノール混液等によシ溶出すれば、い
ずれの成分とも高純度で溶出される。斯くして得られた
各成分を再度シリカゲルカラムクロマトグラフィーに付
し、適当な溶離液例えばクロロホルム・メタノール混液
等により溶出すればSS50732A、B及びCが結晶
状で得られる。なお、上記分離・精製において酢酸ある
いはアンモニアなどの酸性物質あるいは塩基性物質を溶
離液中に添加してもよい。First, after the fermentation has been completed, the culture is converted to p)I2 with hydrochloric acid, and after being left for a while, centrifugation is performed to obtain a residue containing p)I2. This is extracted with a chloroform-methanol mixture (2:1.v/v) in a salt rII acid solution. After distilling off the solvent of the extract and washing with n-hexane or petroleum ether, the residue is subjected to silica gel column chromatography. Next, a suitable l@#i! When eluting with a solution, such as a chloroform/methanol mixture, first SS5
The 0732A fraction was eluted and then the SS50732Bti
ui fraction and further 58507320 fractions are eluted. Furthermore, each portion was treated with Sephadex LH20 (manufactured by Pharmacia).
When subjected to column chromatography and eluted with a suitable eluent, such as a chloroform/methanol mixture, all components can be eluted with high purity. Each component thus obtained is again subjected to silica gel column chromatography and eluted with a suitable eluent such as a chloroform/methanol mixture to obtain SS50732A, B and C in crystalline form. In addition, in the above separation and purification, an acidic substance or a basic substance such as acetic acid or ammonia may be added to the eluent.
以上の如くして得られるSS50732A、B及びCは
、次のような理化学的性質を有する。SS50732A, B and C obtained as described above have the following physical and chemical properties.
■紫外線吸収スペクトル
実線はエタノール中で測定したチャートであム破線は更
に微量の水酸化ナトリウム溶液を添7;II L。■Ultraviolet absorption spectrum The solid line is a chart measured in ethanol. The broken line is a chart obtained by adding a trace amount of sodium hydroxide solution.
て測定したチャートである。第1図は5850732へ
の、第2図は5850732Bの、第3図はSS507
32Cの紫外、線吸収スペクトルを示す。This is a chart of measurements taken. Figure 1 is for 5850732, Figure 2 is for 5850732B, Figure 3 is for SS507.
32C ultraviolet and line absorption spectra are shown.
■赤外線・吸収スペクトル
KJJ r伝により測定した図である。第4図はSS5
0732 Aの1.窮5図はSS50732Bの、第6
図はSS50732Cの赤外線吸収スペクトルを示す。■It is a figure measured by infrared rays absorption spectrum KJJ rden. Figure 4 is SS5
0732 A 1. Figure 5 is SS50732B, No. 6
The figure shows the infrared absorption spectrum of SS50732C.
■分子量
高速液体ゲルクロマトグラフ法により分子量が異なるポ
リエチレングリコールを基準物質として測定した結果S
S50732Aの分子量は1000 、SS50732
Bは950,SS50732Cは900であった。■Molecular weightResults of measuring polyethylene glycol with different molecular weights using high performance liquid gel chromatography as a reference materialS
The molecular weight of S50732A is 1000, SS50732
B was 950, and SS50732C was 900.
■物質の色及び性状
酢酸酸性溶液よりSS50732A、SS50732C
は橙色結晶、SS50732Bは黄緑色結晶として得ら
れる。■Color and properties of substances SS50732A, SS50732C from acetic acid solution
is obtained as orange crystals, and SS50732B is obtained as yellow-green crystals.
■呈色反応 いずれもバニリン硫酸試液、ヨウ素により陽性。■Color reaction Both were positive with vanillin sulfate test solution and iodine.
■溶解性
クロロホルム・メタノール混液に可溶。n−ヘキサン、
水に不溶。■Solubility Soluble in chloroform/methanol mixture. n-hexane,
Insoluble in water.
■薄層クロマトグラフィー
担体;シリカゲルプレー1”ts< (メルク社製)S
S50732A、B、Cは次のような生物学的性質を有
する。■ Thin layer chromatography carrier: Silica gel play 1” TS< (manufactured by Merck & Co., Ltd.) S
S50732A, B, and C have the following biological properties.
■抗菌活性
SS50732A、B、Cの各種微生物に対する最小発
育阻止濃度(MIC)を第1表に示す。■Antibacterial activity The minimum inhibitory concentrations (MIC) of SS50732A, B, and C against various microorganisms are shown in Table 1.
以F Ti ニー’j
■腫瘍細胞増殖阻止作用
SS50732A、B及びCのL5178Y細胞に対す
る増殖阻止作用を下記方法によプ試験した。結果を50
%阻止濃度(ICso)として第2表に示す。■ Tumor cell growth inhibition effect SS50732A, B, and C were tested for growth inhibition effect on L5178Y cells by the following method. 50 results
It is shown in Table 2 as % inhibitory concentration (ICso).
実験方法? L517BY細胞を10%牛脂児血清添加
RPMI 1640培地(GIBcOg)Kて、2 X
10’ l[i/―とし、これにSS50732A、
B、Cを0.001゜0.01 、0.1 、1.0μ
か−の終濃度となるよう添加した。5%炭酸ガス培養器
中で37℃、48時間壇養後、生細胞数を数えた。各濃
度における細胞増殖阻止率からプロビット・グイ7グラ
ム法によ6.5ots阻止濃度(ICffi)を決定し
たつ第2表
〔発明の効果〕
上述の如く、新規抗生物質SS50732A、B及びC
は抗菌剤として有用であるばかシでなく腫瘍細胞に対す
る増殖阻止作用を有することから抗癌剤とし゛ても期待
される化合物である。したがって、本願の微生物は、有
用な抗生物質を生産する優れたものである。experimental method? L517BY cells were cultured 2X in RPMI 1640 medium (GIBcOg) supplemented with 10% tallow serum.
10' l [i/-, and SS50732A,
B, C 0.001°0.01, 0.1, 1.0μ
It was added to a final concentration of -. After culturing in a 5% carbon dioxide incubator at 37°C for 48 hours, the number of viable cells was counted. The 6.5ots inhibitory concentration (ICffi) was determined from the cell proliferation inhibition rate at each concentration using the provit-Gui 7g method.
This compound is not only useful as an antibacterial agent, but also has a growth-inhibiting effect on tumor cells, and is therefore a promising compound as an anticancer agent. Therefore, the microorganisms of the present application are excellent for producing useful antibiotics.
また、これまでに7クチノマジユラ属により発見された
抗生物質はきわめて限られていることにより、アクチノ
マジユラ エスピー 850732株は、培養法のいか
んでは上記8S50732A、B及びC以外にも新規な
抗生物質を生産することが期待される。In addition, since the number of antibiotics that have been discovered so far in the genus Actinomadilla is extremely limited, Actinomadziula sp. expected to be produced.
更に、近年新規抗生物質の発見に遺伝子工学的手法が応
用されつつあるが、アクチノマジユラエスビ−8507
32株は、培養日数がストレプトミセス属とほとんど同
じことより宿主として十分役立つことが期待される。Furthermore, in recent years, genetic engineering methods have been applied to the discovery of new antibiotics;
Since strain 32 can be cultured for almost the same number of days as Streptomyces, it is expected that it will serve well as a host.
次に実施例及び参考例を挙げ、本発明を説明する。 Next, the present invention will be explained with reference to Examples and Reference Examples.
実施例
千葉県夷隅郡において採取し、風乾した±ts1tを滅
菌した生理食塩水9−に懸濁させ、1分間、ミキサーで
攪拌後、上記曳塩水にて10倍段階希釈(10°〜io
−’)する。各希釈液Q、 3 mlを、予め放線菌分
離寒天培地、アクチノミセテ・アイソレーション・アガ
ー(ディ7コ社製)15m/中に分注し、これを固化さ
せた寒天表面に加える。更にその上から、加熱溶解し約
50℃まで冷した上記寒天培地4.5−を加え、混釈後
置める。クリーンペンチ内で無菌的に20分間、寒天表
面を乾燥後、28℃で1箇月間培養した。Example ±ts1t collected in Isumi District, Chiba Prefecture and air-dried was suspended in sterilized physiological saline 9-, stirred with a mixer for 1 minute, and then serially diluted 10 times (10° to io
-'). 3 ml of each diluted solution Q is dispensed in advance into an actinomycete isolation agar medium, Actinomycete Isolation Agar (manufactured by D7CO) 15 m/ml, and this is added to the solidified agar surface. Furthermore, the above agar medium 4.5-, which had been dissolved by heating and cooled to about 50° C., was added on top of the agar medium, and the agar medium was mixed and allowed to stand. After drying the agar surface aseptically for 20 minutes in clean pliers, it was cultured at 28°C for one month.
上記培養により発生するコロニーを白金耳にて下記組成
の斜面寒天培地に移し、28℃で14日間培養する。Colonies generated by the above culture are transferred using a platinum loop to a slanted agar medium having the following composition, and cultured at 28°C for 14 days.
上記培養によシ培地上に発生する菌の1白金耳を生理食
塩水で1,000倍に希釈し、そのl mlを上記放線
菌分離寒天培地;アクチノミセテ・アイソレイション・
アガー(ディ7コ社製)の9vLlと混合し、滅菌シャ
ーレ内で、28℃で14日間培養し、出来た複数のコロ
ニーが相互間に相異しないことを開眼的及び顕微鏡的に
確認する。One platinum loop of the bacteria grown on the above culture medium was diluted 1,000 times with physiological saline, and 1 ml of it was added to the above actinomycete isolation agar medium;
It is mixed with 9vLl of agar (manufactured by D7CO) and cultured in a sterile petri dish at 28°C for 14 days, and it is confirmed visually and microscopically that the resulting colonies are not different from each other.
上記コロニーの内101i1のコロニーを夫々斜面球入
培地に接種し、28℃で14日間培養し、10本の斜面
培地上の菌が肉眼的及び顕微鏡的に同じ菌であることを
確認し、まだこれ等10本の培養菌についての各培地上
の性状及び生理学的性質が同一であることを確認した。Of the above colonies, 101i1 colonies were each inoculated onto a slanted medium and cultured at 28°C for 14 days, and it was confirmed macroscopically and microscopically that the bacteria on the 10 slants were the same. It was confirmed that the properties and physiological properties on each medium of these 10 cultured bacteria were the same.
上記各培地上の性状及び生理学的性質は前述した通シで
6る。The properties and physiological properties of each of the above-mentioned media are as described above.
上記試験の結果釜10本の培養菌はすべて自然界より純
粋に分離された単−菌であることが判る。As a result of the above test, it was found that all of the cultured bacteria in the 10 pots were monobacteria isolated from nature.
次いで上記で純粋培養された斜面寒天培地上の菌に、保
護剤(スキムミルク10%及びグルタミン酸ナトリウム
1チの水溶e、)を加え斜面の胞子懸濁液を凍結乾燥用
アンプルに約0.5 mlずつ分注し、凍結乾燥を行な
う。該凍結乾燥は胞子懸濁液の入ったアンプルをドライ
アイス−アセト/中にて急速凍結し、これを凍結乾燥機
にセットし、真空度が0.03)−ル以下とすることに
より行なわれる。次いでガスバーナーで真空溶封後4°
Cで保存する。斯くして得られる凍結乾燥菌(標品)を
3チ月間保存後、アンプルを開封し、e、歯ミニスパー
チルを用いて滅菌試験管に移し、これに復水液(アイ・
ニス・ピー、ナンバーワン、培地;ISP )/61
med)を加え、1時間以上放置した鏝、前記と同条件
下に各培地上での性状及び生理学的性質を調べた結果、
凍結前の菌(標品)と変化は認められなかった。Next, a protective agent (10% skim milk and 1 g of sodium glutamate dissolved in water) was added to the pure cultured bacteria on the slant agar medium, and about 0.5 ml of the spore suspension on the slant was placed in an ampoule for freeze-drying. Dispense into portions and freeze-dry. The freeze-drying is carried out by quickly freezing the ampoule containing the spore suspension in dry ice-acetate, setting it in a freeze dryer, and setting the degree of vacuum to 0.03) or less. . Then, after vacuum sealing with a gas burner, 4°
Save with C. After storing the freeze-dried bacteria (standard sample) obtained in this way for 3 months, open the ampoule and transfer it to a sterilized test tube using a dental mini-spertill, and add condensate solution (i.e.
Niss Pea, Number One, Medium; ISP)/61
As a result of investigating the properties and physiological properties on each medium under the same conditions as above,
No changes were observed compared to the bacteria before freezing (standard sample).
また上記凍結及び再生を1チ月毎に5度繰り返した菌に
つき同様に、各培地上での性状及び生理学的性質を調べ
た結果変化は認められなかった。Furthermore, the properties and physiological properties of the bacteria on each culture medium were similarly examined after the above-mentioned freezing and regeneration was repeated five times every month, and no changes were observed.
このことより本発明微生物は、継代培養によって確実に
同一結果を再現できることが判る。This shows that the microorganism of the present invention can reliably reproduce the same results by subculture.
参考例
グルコース1%、溶性澱粉2チ、酵母エキス0.3%、
NZアミン1%、コーン−ステイープ・リカー1%、炭
酸カルシウム0.31の組成を有する液体培地とpH7
,0とし、500m1容坂ロフラスコにLOOm1分注
して滅閑する。これに実施−1で得たアクチノマジユラ
エスピー 850732株(a工研菌寄第8613号
)と接種し、28℃で3日間振儒培養してt4培養液と
作成する。次に、グルコース1%、溶性澱粉2チ、綿実
粕2チ、コーン・ステイープ・リカー1%、炭酸カルシ
ウム0.3%の組成を有する液体培地をp)I6.8と
し、304容ジヤー7アメンターに164仕込み滅菌す
る。Reference example glucose 1%, soluble starch 2t, yeast extract 0.3%,
A liquid medium with a composition of 1% NZ amine, 1% corn-steep liquor, 0.31 calcium carbonate and pH 7.
, 0, and dispense 1 LOOml into a 500 ml volume slope flask to evaporate. This was inoculated with the Actinomadilla sp. 850732 strain (A Koken Bacteria No. 8613) obtained in Example 1, and cultured under shaking at 28° C. for 3 days to prepare a t4 culture solution. Next, a liquid medium having a composition of 1% glucose, 2 t of soluble starch, 2 t of cottonseed meal, 1% corn steep liquor, and 0.3% calcium carbonate was prepared as p)I6.8, and 304 volumes of jar 7 Pour 164 into an Amentor and sterilize.
これに前記の種培養C夜160rnlを接種し、培養温
度28℃、攪拌a40Orpm、通気−1i16[7分
の条件下で5日間培資する。なお培養時のpHの上昇を
防止するために令酢酸・クエン酸混液によりpi−17
,8に維持培養した。斯くして得られた培養液166を
塩酸によりpH2に調整し、しばらく攪拌し遠心分離す
ることにより残渣を得たっこの残渣にクロロホルム/メ
タノール(2:1)混液8eを加え攪拌放fitf&ク
ロロホルム/メタノール層と残直に分離する。再び残渣
にクロロホルム/メタノール(2:1)混液8pを加え
、攪拌放置後クロロホルム/メタノール抽出液を得て、
先の抽出液と合せて溶媒を減圧留去し粗抽出物を得た。This was inoculated with 160 rnl of the above-mentioned seed culture C, and cultured for 5 days under conditions of a culture temperature of 28° C., stirring at 40 rpm, and aeration of 1/16 [7 min]. In addition, to prevent the pH from increasing during culture, pi-17 was incubated with a mixture of acetic acid and citric acid.
, 8. The culture solution 166 thus obtained was adjusted to pH 2 with hydrochloric acid, stirred for a while, and then centrifuged to obtain a residue. To this residue, a chloroform/methanol (2:1) mixture 8e was added, stirred, and left to stir. Separate into layers and residual layers. Add 8 parts of a chloroform/methanol (2:1) mixture to the residue again, and after stirring, obtain a chloroform/methanol extract.
The solvent was distilled off under reduced pressure in combination with the previous extract to obtain a crude extract.
この粗抽出物をn−へキサンで洗った後シリカゲル(メ
ルク社iRKii=se1ge160.230〜400
メツシュ)カラムクロマトグラフィー(4,5(φ)X
33m)に付す。最初にクロロホルム500m7で展開
した後、クロロホルム/メタノール(98:2)混液2
2で展開すれば、まずSS50732C画分が溶出する
。更に同(9:1)混液26で展開すればSS5073
2B画分が溶出し、更に同(4: 1. )混液2、e
で展開すればSS50732A画分が溶出される。After washing this crude extract with n-hexane, silica gel (Merck iRKii = se1ge160.230-400) was used.
mesh) column chromatography (4,5 (φ)
33m). After first developing with 500 m7 of chloroform, 2 ml of chloroform/methanol (98:2) mixture
2, the SS50732C fraction is eluted first. Furthermore, if you develop it with the same (9:1) mixture 26, SS5073
The 2B fraction was eluted, and the same (4:1.) mixture 2, e
When developed, the SS50732A fraction is eluted.
(+)SS50732Aの精製
SS50732A画分をセファデックスL)(20(フ
ァルマシア社製)カラムクロマトグラフィー(3,0φ
x 45 cm )に付し、クロロホルム/メタノール
(2:L)混液で展開すれば純度の高いSS50732
A画分750#?が溶出される。更にこの画分をシリカ
ゲル(メルク社製Kiese1ge160 、230〜
400メツシユ)カラムクロマトグラフィー(3,0φ
×30 cm )に付し、クロロホルム/メタノール/
酢酸(80:20;0.5)で展開すれば高純度のSS
50732A画分が溶出した。得られた画分の溶媒全減
圧留去したL n−ヘキサンにより洗うことにより、S
S50732Aの純品350習を得た。(+) The purified SS50732A fraction of SS50732A was purified by Sephadex L) (20 (manufactured by Pharmacia) column chromatography (3,0φ
x 45 cm) and developed with a chloroform/methanol (2:L) mixture to obtain highly pure SS50732.
A fraction 750#? is eluted. Furthermore, this fraction was purified by silica gel (Merck Kieselge160, 230~
400 mesh) column chromatography (3,0φ
×30 cm) and chloroform/methanol/
High purity SS can be obtained by developing with acetic acid (80:20; 0.5)
The 50732A fraction was eluted. S
I got 350 copies of pure S50732A.
本物質について薄層クロマトグラフィー及び高速液体ク
ロマトグラフィーにより単品であること及び前記した理
化学的性質を有していることを確かめた。This substance was confirmed by thin layer chromatography and high performance liquid chromatography to be a single substance and to have the above-mentioned physical and chemical properties.
(II) S S 50732 Bの精製SS 507
32B画分をセファデックスL)I20 (ファルマシ
ア社製)カラムクロマトグラフィー(3,Oφx 45
cm )に付し、クロロホルム/メタノール(2:1
)混液で展開すれば純度の高いSS50732B画分8
00 m9が溶出される。更にこの両分をシリカケル(
メルク社製Kiese1ge160.230〜400メ
ンシユ)カラムクロマトグラフィー(3,0φ×30
cm )に付し、クロロホルム/メタノール/酢酸(9
0:10:0.5)で展開すれば高純度のSS5073
2B画分が溶出した。得られた両分の溶媒を減圧留去し
た後、n−ヘキサンにより洗うことにより、SS507
32Bの純品3401ダを得た。(II) Purification of SS 50732 B SS 507
The 32B fraction was subjected to Sephadex L) I20 (manufactured by Pharmacia) column chromatography (3, Oφx 45
cm) and chloroform/methanol (2:1
) Highly pure SS50732B fraction 8 when developed with a mixed solution
00 m9 is eluted. Furthermore, these two parts are silica gel (
Merck & Co., Ltd. Kiese1ge160.230-400 mesh) column chromatography (3,0φ x 30
cm ) and chloroform/methanol/acetic acid (9
0:10:0.5) to obtain high purity SS5073.
Fraction 2B was eluted. After distilling off both obtained solvents under reduced pressure, SS507 was washed with n-hexane.
I got a pure product of 32B, 3401 da.
本物質は薄層クロマトグラフィーあるいは高速液体クロ
マトグラフィーにより単品であることが証明されるばか
シでなく前記した理化学的性質を有していることを確か
めた。It was confirmed by thin layer chromatography or high performance liquid chromatography that this substance is not a single substance and has the physical and chemical properties described above.
(III) S S 50732 Cの精製SS507
32C画分をセファデックスL1(20(ファルマシア
社JR)カラムクロマトグラフィー(3,Oφx 4.
5 cm )に付し、クロロホルム/メタノール(2:
1)混液で展開すれば純度の高い8S50732C画分
280即が溶出される。更にこの両分をシリカゲル(メ
ルク社JRKiese1ge160.230〜400メ
ツシュ)カラムクロマトグラフィ(2,OφX35百)
に付しクロロホルム/メタノール/酢!(9s:2:0
.5)で展開すれば高純度のSS50732C画分が溶
出した。得られた両分の溶媒を減圧留去した後、n−ヘ
キサンにより洗うことによりSS50732Cの純品1
10ηを得た。本物質について薄層クロマトグラフィー
及び高速液体クロマトグラフィーにより単品であること
、及び前記した理化学的性質を有していることを確かめ
た。(III) Purification of SS50732C SS507
The 32C fraction was subjected to Sephadex L1 (20 (Pharmacia JR) column chromatography (3, Oφx 4.
5 cm) and chloroform/methanol (2:
1) If the mixture is developed, a highly pure 8S50732C fraction of 280% will be eluted. Furthermore, these two fractions were subjected to silica gel (Merck JRKieselge160.230-400 mesh) column chromatography (2,0φX3500).
Chloroform/methanol/vinegar! (9s:2:0
.. 5), a highly pure SS50732C fraction was eluted. After distilling off both the obtained solvents under reduced pressure, the pure product 1 of SS50732C was obtained by washing with n-hexane.
10η was obtained. This substance was confirmed by thin layer chromatography and high performance liquid chromatography to be a single substance and to have the above-mentioned physical and chemical properties.
第1図はSS50732Aの、第2図はSS50732
Bの、第3図はSS50732Cの紫外線吸収スペクト
ルを示す図面である。
第4図はSS50732Aの、第5図はSS50732
Bの、第6図はSS50732Cの赤外線吸収スペクト
ルを示す図面である。
以上。Figure 1 shows SS50732A, Figure 2 shows SS50732.
FIG. 3 of B is a drawing showing the ultraviolet absorption spectrum of SS50732C. Figure 4 shows SS50732A, Figure 5 shows SS50732.
FIG. 6 of B is a drawing showing the infrared absorption spectrum of SS50732C. that's all.
Claims (1)
732A、B及びC生産菌。1. SS50, a novel antibiotic belonging to the genus Actinomagilla
732A, B and C producing bacteria.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3010086A JPS62186787A (en) | 1986-02-14 | 1986-02-14 | Novel microorganism |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3010086A JPS62186787A (en) | 1986-02-14 | 1986-02-14 | Novel microorganism |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS62186787A true JPS62186787A (en) | 1987-08-15 |
Family
ID=12294357
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3010086A Pending JPS62186787A (en) | 1986-02-14 | 1986-02-14 | Novel microorganism |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS62186787A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990015062A1 (en) * | 1989-06-01 | 1990-12-13 | Pfizer Inc. | Novel acidic polycyclic ether antibiotics and microorganisms useful in the production thereof |
US5602012A (en) * | 1987-10-26 | 1997-02-11 | Pfizer Inc. | Microbiological process for making UK-61,689 |
-
1986
- 1986-02-14 JP JP3010086A patent/JPS62186787A/en active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5602012A (en) * | 1987-10-26 | 1997-02-11 | Pfizer Inc. | Microbiological process for making UK-61,689 |
US5679563A (en) * | 1987-10-26 | 1997-10-21 | Pfizer Inc. | Actinomadura roseorufa for making UK-61,689 |
US5693524A (en) * | 1987-10-26 | 1997-12-02 | Pfizer Inc. | Anticoccidial composition of UK-61 689 and Actinomadura mycelium |
WO1990015062A1 (en) * | 1989-06-01 | 1990-12-13 | Pfizer Inc. | Novel acidic polycyclic ether antibiotics and microorganisms useful in the production thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS62186787A (en) | Novel microorganism | |
JP2592468B2 (en) | Benanomycins A and B, novel antibiotics and their production | |
JPH0625095B2 (en) | Antibiotic SF-2415 substance and its production method | |
JPS59170092A (en) | Novel antibiotic, ss8201d and its preparation | |
JPH10114777A (en) | Antibiotic substance spiroximicin and its production | |
JPH03227971A (en) | Carbazole compound | |
JP3796539B2 (en) | Method for producing glyceroglycolipid and microorganism used therefor | |
JPS6348284A (en) | Novel antibiotic yp-02908l-a and production thereof | |
JPH09157266A (en) | New antibiotic epoxynomicin a and b and their production | |
JPS6034556B2 (en) | Antibiotic C-15003 | |
JPH0625277A (en) | Bacterium producing novel testosterone-5alpha-reductase-inhibiting substance, sna-4606, novel testosterone-5-reductase-inhibiting substance, sna-4606 and its production | |
JPH11217382A (en) | Antibiotic tubelactomicin and its production | |
JPH08165286A (en) | Antibiotic tetromycin a and b, and its production | |
JPH02202867A (en) | Alpha,beta-unsaturated azoxy compound | |
JPH03220196A (en) | Benzanthraquinone compound | |
JPH08208644A (en) | New antibiotic substance cremimycin, its production and use | |
JPH11193280A (en) | New antibiotics decatromicin a and b and production of the same | |
JPS589690A (en) | Antibiotic am-5344-a1 and its preparation | |
JPH0680607A (en) | Malbranicin | |
JPH04279555A (en) | Novel beta-glucuronidase-inhibiting substance, 7-hydroxybenanomicinone and its production | |
JPS63162697A (en) | Novel antibiotic substance sf-2415a3 and sf-2415b3 and production thereof | |
JPH0417199B2 (en) | ||
JPS61115081A (en) | Novel antibiotic ss21020d and production thereof | |
JPH02200669A (en) | Antibiotic substance mi424-38f1, salt and production thereof | |
JPH0366308B2 (en) |